Article citationsMore>>

Eastham, J.A., Auffenberg, G.B., Barocas, D.A., Roger Chou, R., Crispino, T., Davis, J.W., Eggener, S., Horwitz, E.M., Kane, C.J., Kirkby, E., Lin, D.W., McBride, S., Morgans, A.K., Pierorazio, P.M., Rodrigues, G., Wong, W.W. and Boorjian, S.A. (2022) Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. The Journal of Urology, 208, 10-18.
https://doi.org/10.1097/JU.0000000000002757

has been cited by the following article:

• TITLE: Trifecta Outcomes of Screening Detected and Patients with Lower Urinary Tract Symptoms after Open Radical Prostatectomy for Localized Prostate Cancer

  AUTHORS: Mathew Yamoah Kyei, James Edward Mensah, Robert Djagbletey, Evans Akpali, Francis Ahiaku, Ali Ayamba, Ben Adusei, Enoch Tackie, Emmanuel Bannerman-Williams, George Oko Klufio

  KEYWORDS: Screening, Lower Urinary Tract Symptoms, Open Radical Prostatectomy, Functional Outcome, Trifecta

  JOURNAL NAME: Open Journal of Urology, Vol.13 No.8, August 10, 2023

  ABSTRACT: Background: Many studies have reported on trifecta outcomes after radical prostatectomy. There is however paucity of studies that compares the trifecta outcome between screen detected and patients presenting with lower urinary symptoms with localized prostate cancer after radical prostatectomy. This study compares the trifecta outcomes between these two groups after an open retropubic radical prostatectomy. Methodology: This is a retrospective study, on the trifecta outcomes (urinary continence, erectile function, and cancer control) of consecutive patients that had open radical retropubic prostatectomy for localized prostate cancer by a single surgeon. Patients were grouped into screen detected and presentation with lower urinary symptoms or retention of urine. The parameters considered were the age of the patients, the total prostate specific antigen (tPSA) at presentation, the clinical T stage, the Gleason score of prostate biopsies, the risk categories using the D’Amico risk groups and the trifecta outcomes after the procedure. Results: In all, 119 patients met the criteria for inclusion. The median follow up was 63.5 months (range 12 - 156 months). Of these 40.3% of the patients were diagnosed through screening with elevated PSA while 59.7% had presented with symptoms of lower urinary tract obstruction. The mean age for the patients was 60.8 ± 6.5 years, median PSA 12.6 ng/ml (IQR 8.6 - 19.7) and median prostate weight of 50.0 (IQR 40.0 - 60 g). The urinary continence rate after the procedure was 93.3%, erection rate of 81.5%, cancer control rate of 71.4% and trifecta achieved in 57.1%. Comparing the screening and the symptomatic cases, the urinary continence rate was 91.7% vrs 94.3%; erectile function rate was 79.2% vrs 83.1%; cancer control 68.8% vrs 73.2% and trifecta achieved in 58.3% vrs 56.3%. There was no statistically significant difference between the two groups in terms of urinary continence p = 0.564, erection function p = 0.588, cancer control p = 0.595, and achieving trifecta p = 0.829. Conclusion: Patients with localized prostate cancer presenting with lower urinary symptoms compared to screen detected patients have similar outcomes in terms of urinary Continence, erectile function, cancer control and trifecta after open radical retropubic prostatectomy.